Morningstar

Front Month Nymex ULSD Rose 5.27% This Week to Settle at $4.7384 — Data Talk

Provided by Dow Jones

Front Month Nymex ULSD for Nov. delivery gained 23.73 cents per gallon, or 5.27% to $4.7384 this week 




       --Largest one week net and percentage gain since the week ending Sept. 11, 2026 



       --Snaps a two week losing streak 



       --Up seven of the past nine weeks 



       --Today it is down 14.45 cents or 2.96% 



       --Largest one day dollar decline since Wednesday, Sept. 23, 2026 



       --Largest one day percentage decline since Friday, Oct. 2, 2026 



       --Snaps a four session winning streak 



       --Off 9.95% from its 52-week high of $5.262 hit Tuesday, Sept. 15, 2026 



       --Up 130.39% from its 52-week low of $2.0567 hit Wednesday, Jan. 7, 2026 



       --Rose 114.95% from 52 weeks ago 



       --Off 9.95% from its 2026 settlement high of $5.262 hit Tuesday, Sept. 15, 2026 



       --Up 130.39% from its 2026 settlement low of $2.0567 hit Wednesday, Jan. 7, 2026 



       --Off 9.95% from its record high of $5.262 hit Tuesday, Sept. 15, 2026 



       --Month-to-date it is down 4.41% 



       --Year-to-date it is up $2.6178 or 123.45% 





     All prices are calculated based on the settlement price of the current front month contract. 





     Source: Dow Jones Market Data 





  (END) Dow Jones Newswires



  October 09, 2026 15:02 ET (19:02 GMT)


Copyright (c) 2026 Dow Jones & Company, Inc.
  

					The articles, information, and content displayed on this webpage may
					include materials prepared and provided by third parties. Such
					third-party content is offered for informational purposes only and
					is not endorsed, reviewed, or verified by Morningstar.
				
 

					Morningstar makes no representations or warranties regarding the
					accuracy, completeness, timeliness, or reliability of any third-party
					content displayed on this site. The views and opinions expressed in
					third-party content are those of the respective authors and do not
					necessarily reflect the views of Morningstar, its affiliates, or employees.
				
 

					Morningstar is not responsible for any errors, omissions, or delays
					in this content, nor for any actions taken in reliance thereon.
					Users are advised to exercise their own judgment and seek independent
					financial advice before making any decisions based on such content.
					The third-party providers of this content are not affiliated with
					Morningstar, and their inclusion on this site does not imply any
					form of partnership, agency, or endorsement.
				
 

				Popular
				
 
  
 
 
 
 
The Smartest Moves for Bond Investors Today, and What to Do When You Have Too Many Investments
 
Ask the Analyst columnist Amy Arnott answers a grab bag of reader questions about bond ETFs, TIPS, retirement planning, and more. 
 
 
Amy C. Arnott, CFA and Ivanna Hampton 
 
 
 
Undervalued by 15%, This Utilities Stock Could Be an Unexpected AI Winner
 
With a 3.3% dividend yield and earnings growth expected to exceed management’s outlook, this 4-star stock stands out in a struggling sector. 
 
 
Andrew Bischof, CFA, CPA 
 
 
 
The Thrilling 37
 
Just a few strict screens can narrow the field to an elite group of funds. 
 
 
Russel Kinnel 
 
 
 
3 Stocks to Sell and 3 Stocks to Buy for October
 
Plus, lessons from September’s stock market activity. 
 
 
David Sekera, CFA and Susan Dziubinski 
 
 
 
The 10 Best and 10 Worst Months of All Time for the US Stock Market
 
Do common investor sayings about particular months being stronger or weaker for stocks have empirical backing, or is it all market mythology? Dan Lefkovitz uncovered some surprising truths about stock market performance by examining over 100 years of data. 
 
 
Dan Lefkovitz 
 
 
 
 

			Sponsor Center